Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Laser Diffraction Method Optimization – V 2.0

Posted on By

Analytical Method Development: Laser Diffraction Method Optimization – V 2.0

Standard Operating Procedure for Laser Diffraction Method Optimization in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/116/2025
Supersedes SOP/AMD/116/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP defines the method optimization procedure for laser diffraction-based particle size analysis, used to determine the distribution of particle sizes in active pharmaceutical ingredients (APIs), excipients,

and formulated drug products.

2. Scope

This SOP is applicable to all method optimization work involving laser diffraction techniques within the Analytical Method Development (AMD) department. It covers dry and wet analysis, dispersion optimization, repeatability studies, and span analysis.

3. Responsibilities

  • Analytical Scientist: Develops and optimizes the method, selects conditions, and evaluates results.
  • Instrument Operator: Performs instrument calibration, setup, and measurements.
  • QA Officer: Ensures compliance with documentation and analytical guidelines.
  • Head – AMD: Approves the optimized method protocol for further validation.

4. Accountability

The Head of Analytical Method Development is accountable for scientific accuracy, reproducibility, and compliance of the optimized laser diffraction method.

See also  Analytical Method Development: SOP for Determination of Residual Solvents in Parenterals - V 2.0

5. Procedure

5.1 Instrument Setup and Calibration

  1. Switch on the laser diffraction instrument (e.g., Malvern Mastersizer) and allow stabilization.
  2. Perform background calibration using manufacturer guidelines.
  3. Validate the alignment, cleanliness of sample cell, and laser intensity baseline.
  4. Check that the software version is compatible with lab systems.
  5. Log in Annexure-1: Instrument Calibration Record.

5.2 Selection of Analysis Mode

  1. Choose between:
    • Dry Dispersion: For non-hygroscopic, flowable powders
    • Wet Dispersion: For poorly flowable or cohesive materials
  2. Select appropriate dispersion unit (e.g., Aero S for dry or Hydro EV for wet).
  3. Record analysis mode and justification in Annexure-2: Mode Selection Log.

5.3 Optimization of Dispersion Parameters

  1. Identify optimal dispersion conditions:
    • Obscuration between 10–20%
    • Sonication (wet) or air pressure (dry) to minimize agglomeration
    • Stirrer speed (wet: 500–2500 rpm)
  2. Conduct trials to determine:
    • Lowest span value with reproducible D10, D50, D90
    • Minimal variation across replicates (RSD < 3%)
  3. Log trials in Annexure-3: Dispersion Optimization Summary.

5.4 Refractive Index Settings

  1. Select appropriate refractive index (RI) and absorption values based on compound class:
    • Standard RI values: API (1.60–1.65), Excipients (1.45–1.55)
  2. If unknown, conduct trial runs with estimated values and confirm with microscopy data.
  3. Document in Annexure-4: RI Configuration Log.
See also  Analytical Method Development: SOP for Stability-Indicating Method for Lyophilized Injections - V 2.0

5.5 Repeatability and Robustness Testing

  1. Perform a minimum of six repeat measurements (same sample, same day).
  2. Calculate mean, standard deviation, and %RSD for D10, D50, and D90.
  3. Perform same-day and inter-day robustness by varying dispersion time or stirring speed.
  4. Evaluate shift in span and curve consistency.
  5. Record data in Annexure-5: Repeatability and Robustness Log.

5.6 Method Acceptance Criteria

  1. Accept method if:
    • D50 values are consistent (RSD < 3%)
    • Span < 2.0 for mono-modal distributions
    • Obscuration stable across runs
  2. Document final optimized parameters in Annexure-6: Final Method Sheet.

6. Abbreviations

  • D10, D50, D90: Particle diameter at 10%, 50%, and 90% cumulative volume
  • PSD: Particle Size Distribution
  • RI: Refractive Index
  • RSD: Relative Standard Deviation
  • SOP: Standard Operating Procedure

7. Documents

  1. Instrument Calibration Record – Annexure-1
  2. Mode Selection Log – Annexure-2
  3. Dispersion Optimization Summary – Annexure-3
  4. RI Configuration Log – Annexure-4
  5. Repeatability and Robustness Log – Annexure-5
  6. Final Method Sheet – Annexure-6

8. References

  • USP <429> – Light Diffraction Measurement of Particle Size
  • ICH Q2(R1) – Validation of Analytical Procedures
  • Instrument Manufacturer’s Method Optimization Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Instrument Calibration Record

Date Instrument Calibration Status Performed By
18/05/2025 Mastersizer 3000 Pass Sunita Reddy

Annexure-2: Mode Selection Log

Wet dispersion selected for sample PSD-116 due to cohesive nature and aggregation in dry conditions.

Annexure-3: Dispersion Optimization Summary

Trial Stir Speed Sonication D50 Span
1 1500 rpm Yes 7.4 1.8

Annexure-4: RI Configuration Log

Sample RI Used Absorption Source
API-B 1.60 0.01 Manufacturer Data

Annexure-5: Repeatability and Robustness Log

Run D50 Span Obscuration
1 7.3 1.9 12%
2 7.4 1.8 13%

Annexure-6: Final Method Sheet

Method: Wet laser diffraction using Mastersizer 3000, water + 0.1% Tween 80, stirrer 1800 rpm, 60 s measurement, RI: 1.60, Absorption: 0.01. Acceptable D50 and span confirmed over 6 replicates.

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Expanded robustness testing and added RI configuration Annual Review
See also  Analytical Method Development: BET Method Development (Bacterial Endotoxins Test) - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Handling Deviations in Manufacturing Stages – V 2.0
Next Post: API Manufacturing: SOP for Archival of QA Records and BMRs – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version